The protein kinase encoded by the Akt proto-oncogene is activated by phospholipid binding, membrane translocation and phosphorylation. To address the relative roles of these mechanisms of Akt activation, we have employed a combination of genetic and pharmacological approaches. Transient transfection of NIH3T3 cells with wild-type Akt, pleckstrin homology (PH) domain mutants, generated on the basis of a PH domain structural model, and phosphorylation site Akt mutants provided evidence for a model of Akt activation consisting of three sequential steps: (1) a PH domain-dependent, growth factor-independent step, marked by constitutive phosphorylation of threonine 450 (T450) and perhaps serine 124 (S124), that renders the protein responsive to subsequent activation events; (2) a growth factor-induced, PI3-K-dependent membrane-translocation step; and (3) a PI3-K-dependent step, characterized by phosphorylation at T308 and S473, that occurs in the cell membrane and is required for activation. When forced to translocate to the membrane, wild-type Akt and PH domain Akt mutants that are defective in the ®rst step become constitutively active, suggesting that the purpose of this step is to prepare the protein for membrane translocation. Both growth factor stimulation and forced membrane translocation, however, failed to activate a T308A mutant. This, combined with the ®nding that T308D/S473D double mutant is constitutively active, suggests that the purpose of the three-step process of Akt activation is the phosphorylation of the protein at T308 and S473. The proposed model provides a framework for a comprehensive understanding of the temporal and spatial requirements for Akt activation by growth factors.
Introduction
Cytoplasmic serine-threonine protein kinases are activated by a variety of mechanisms in response to extracellular signals (Nishizuka, 1995; Downward, 1995; Marshall, 1996) . Akt, one of these kinases, is notable in that it is a direct target of the phosphatidylinositol 3-kinase (PI3-K) Kohn et al., 1995; Andjelkovic et al., 1996; Burgering and Coer, 1995; Klippel et al., 1996; Datta et al., 1996) , and as such it plays an important role in regulating many cellular functions that depend on the activity of this enzyme (Kapeller and Cantley, 1994) . The activation of Akt by PI3-K was determined by experiments mapping the pathway that regulates Akt following stimulation by a variety of growth factors Kohn et al., 1995; Burgering and Coer, 1995) . This was con®rmed by studies showing that the activated catalytic subunit of the PI3-K is sucient to activate Akt in the absence of growth factor stimulation (Klippel et al., 1996; Datta et al., 1996) . Our early studies, identifying Akt as a direct target of the PI3-K, showed that an Akt immunoprecipitate from lysates of serum-starved NIH3T3 cells was activated when incubated with D3 phosphorylated phosphoinositides (D3 PPIs) . Since the activation of Akt by PDGF requires an intact Akt pleckstrin homology (PH) domain and since PH domains bind phospholipids (Harlan et al., 1994; Hyvonen et al., 1995) , these ®ndings suggested that Akt activation may depend on the binding of D3 PPIs to the Akt PH domain . This was con®rmed and extended by studies that examined the role of de®ned D3 PPIs in Akt activation. Two such recent studies indeed showed that, although PI(3,4,5)P3 and PI(3,4)P2 both bind the PH domain of Akt in vitro, only PI(3,4)P2 activates Akt (Klippel et al., 1997; Franke et al., 1997) .
The simple scheme of direct Akt activation by binding to the PI3-K-generated phospholipids was challenged when it was shown that phosphorylation also contributes to Akt activation. First, it was shown that Akt is activated by stress signals via mechanisms that are PI3-K-independent (Konishi et al., 1996) . More important, the PI3-K-dependent activation of Akt by growth factors was also shown to require phosphorylation (Kohn et al., 1996) . Stimulation of 293 cells with IGF-1 led to the phosphorylation of Akt at threonine 308 in the activation loop of the kinase and serine 473 in the carboxy-terminal tail, and phosphorylation of both sites was shown to contribute to Akt activation (Alessi et al., 1996) . Recent studies have shown that at least two kinases, PDK1 and PDK2, are responsible for the growth factor-induced phosphorylation of Akt (Alessi et al., 1997a,b; Stokoe et al., 1997) . It is interesting that the phosphorylation of Akt by PDK1 also depends on PI3-K-generated phospholipids (Alessi et al., 1997a,b; Stokoe et al., 1997) . This raises the question whether the phospholipids render Akt a good substrate for PDK1 or whether they activate PDK1. The constitutive kinase activity of the recently cloned PDK1 would argue in favor of the ®rst possibility (Alessi et al., 1997b) as though it does not exclude that the phospholipids may have a dual role (Stokoe et al., 1997) .
Following growth factor stimulation, Akt translocates to the cell membrane (Ahmed et al., 1997) . Since myristylated mutants of Akt that are constitutively associated with the membrane are also constitutively active (Ahmed et al., 1997; Kohn et al., 1996) , it has been proposed that membrane translocation contributes to the activation of Akt. This was con®rmed recently by experiments showing that membraneassociated but not cytosolic Akt, isolated from growth factor-stimulated cells, is catalytically active (Zhang and Vik, 1997) .
This report provides a systematic examination of the temporal and spatial order of the mechanisms that collectively contribute to the activation of Akt by growth factors. The studies reported here were based on a combination of genetic and pharmacological approaches and support a three-step model for Akt activation. The ®rst step is PH domain-dependent and growth factor-independent and consists of events that prepare Akt to respond to growth factor stimulation. This step is aected by mutations in residues, all of which, with one exception, are expected to be involved in phospholipid binding, as predicted by a structural model of the Akt PH domain we generated. The second step, which is growth factor and PI3-Kdependent, is de®ned by the translocation of Akt to the cell membrane. The third step is de®ned by the phosphorylation of Akt by membrane-associated kinases. Phosphorylation at threonine 308 by a kinase that is activated by PDGF via PI3-K, is required for Akt activation.
The proposed model provides a framework for the comprehensive understanding of the temporal and spatial requirements for Akt activation by growth factors.
Results

A structural model of the Akt PH domain
The Akt proto-oncogene encodes a serine-threonine protein kinase which contains an aminoterminal PH domain (a.a. 1 ± 109) and a catalytic domain (a.a. 148 ± 411) closely related to the catalytic domains of PKA and all the members of the PKC kinase family (Bellacosa et al., 1991 (Bellacosa et al., , 1993 . The PH domain, a motif found in a wide range of proteins involved in signal transduction (Haslam et al., 1993; Mayer et al., 1993) is linked to the kinase domain by a highly acidic segment of 37 amino acids (a.a. 110 ± 147). The remaining residues (412 ± 480) constitute the carboxyterminal tail of the kinase.
The structure of several PH domains has been determined (Ferguson et al., 1994 (Ferguson et al., , 1995 Fushman et al., 1995; Hyvonen et al., 1995; Macias et al., 1994; Timm et al., 1994; Yoon et al., 1994) . These structures exhibit a common globular fold that consists of seven anti-parallel b strands and an a helix (Gibson et al., 1994; Lemmon et al., 1996) . The b strands are arranged into two sheets that are positioned approximately orthogonal to each other while the a helix caps o an opening between the sheets, thus enclosing a stable hydrophobic core. One of the interesting features of the PH domain is that it has a surface patch with a distinctive positive electrostatic potential which is believed to bind phospholipids (Lemmon et al., 1996) . Indeed, in the PH domain of phospholipase Cd, inositol triphosphate, Ins(1,4,5)P3, was shown to occupy this surface (Ferguson et al., 1995) . Dierent PH domains exhibit great sequence diversities but share a similar globular fold. Structure-based sequence alignments revealed that variable sequence lengths are often found in the loop regions (Ferguson et al., 1995) . These apparently dierent loop structures generate diverse ligand binding surfaces that are accommodated within the common fold. These surfaces in the PH domain bind phospholipids, while in the PTB domain, a variant of the PH domain, bind phosphotyrosine (Lemmon et al., 1996) .
To determine the role of the Akt PH domain in Akt activation by growth factors we generated a series of Akt PH domain mutants by site-directed mutagenesis. The selection of sites to be mutated was based on a structural model of the PH domain, built by comparative modeling. To build the Akt PH domain model we examined the sequence homology between this domain and other PH domains whose three-dimensional structure is known. Sequence alignments revealed that the ®rst 45 residues in the PH domain of Akt share higher homology with the amino-terminal region of the PH domain of PLCd than with the corresponding regions of other structurally de®ned PH domains. The remaining 64 residues in the carboxy-terminal portion of the Akt PH domain show more homology to the pleckstrin N PH domain. Based on these ®ndings, we built the Akt PH domain model by comparison to a hybrid structural template derived from the PH domains of PLCd and pleckstrin N.
Our model structure has the known globular fold of the PH domain ( Figure 1a ). Electrostatic potential calculations revealed a distinctive positive surface patch in the region between b strands 1 and 2, and the loop connecting b strands 3 and 4 ( Figure 1b ). Residues K14, R15, R25, K39 and R41 were identi®ed as the main contributors to this positive surface. Within this surface, a pocket, which is likely to be involved in phospholipid binding, was identi®ed. Residues R15, R25 and E40 are pointing into the proposed pocket. Interestingly, the recently published crystal structure of the PH domain of Btk shows that residues K12, R28, and E41 (which correspond to residues R15, R25 and E40 in Akt) are also located in a well de®ned lipid binding pocket (Hyvonen and Saraste, 1997) . Residues in the positive surface patch were selected for mutation. Residue W22 was also selected for mutation because it aligns with W36 of PLCd, a residue found to interact with one of the phosphate groups of Ins(1,4,5)P3 (Ferguson et al., 1995) . Mutants of the PH domain of Akt, generated on the basis of this model ( Figure 1a and Table 1 ), were examined for basal kinase activity and responsiveness to PDGF stimulation. Mutations at amino acid E40 enhance the basal kinase activity and marginally enhance responsiveness to PDGF. Mutations in the residues predicted to be involved in phospholipid binding abolish (R15A, W22A, R25A, R25C, R25E) or markedly reduce (P42A) Akt kinase activity. Akt mutants in residues that are not predicted to make contacts with phospholipid exhibit normal basal kinase activity and PDGF responsiveness (K39A, R41A), with the exception of the K14A mutant which is inactive. The kinase inactive mutant K179M is a negative control. These results are representative of those obtained from ®ve (E40 and R25 mutants) or three experiments (rest of the mutants)
Akt PH domain mutants vary in basal kinase activity and responsiveness to growth factors To functionally analyse the Akt PH domain mutants shown in Table 1 , NIH3T3 cells were transiently transfected with CMV5 or CMV5-based expression constructs of wild-type and kinase-inactive (K179M) Akt and the aforementioned Akt PH domain mutants. All proteins were tagged with a hemagglutinin epitope tag (HA) at their amino-terminus. Twenty-four hours later, the cells were serum-starved for 16 h. They were then lysed in an NP-40 lysis buer before or 10 min after stimulation with PDGF. Some of the cultures were treated with the PI3-K inhibitor wortmannin (200 nM) for 40 min prior to growth factor stimulation. In vitro kinase assays of Akt, immunoprecipitated from these lysates with the anti-HA monoclonal antibody HA11, revealed that all mutants in the putative phospholipid binding pocket, with the exception of the E40 mutants, had decreased basal kinase activity and did not respond to PDGF stimulation. Of three additional mutants in residues outside the putative phospholipid binding pocket, two (K39A and R41A) exhibited normal responsiveness to PDGF stimulation while the third (K14A) failed to respond ( Figure 1c ). All the E40 mutants (E40A, E40C and E40K) exhibited enhanced basal kinase activity and marginally enhanced responsiveness to PDGF stimulation. However, they were sensitive to wortmannin, suggesting that their activation is still PI3-K-dependent (Figure 1c ). Multiple structure-based sequence alignments showed that amino acid E40 in the PH domain of Akt corresponds to amino acid E41 in the PH domain of Btk and E54 in the PH domain of PLCd. Interestingly, mutations at these sites in Btk and PLCd also enhance the biological activity of these proteins. Speci®cally, the Btk E41K mutation enhances the transforming potential of Btk in NIH3T3 cells (Li et al., 1995) and the PLCd E54K mutation increases the anity of the PLCd PH domain to phospholipids and enhances the enzymatic activity of the protein (Bromann et al., 1997) . Based on these considerations, we propose that E40 mutations increase the basal kinase activity of Akt by enhancing the anity of its PH domain to PI3-Kgenerated phospholipids, due to the removal of the glutamic acid negative charge from the phospholipid binding pocket. The higher basal activity of the E40 mutants may therefore result from their increased binding to D3 PPIs which persist at low levels even after 24 h of serum starvation (Khwaja et al., 1997) .
The enhanced basal kinase activity of the Akt E40K mutant is sucient to elicit the biological eects associated with activated Akt. Thus, Akt E40K, but not wild-type Akt, inhibits apoptosis of BAF3 cells induced by growth factor withdrawal (Ahmed et al., 1997) . In addition, E40K complements the oncogenic potential of BCR-ABL mutants that fail to activate Akt and fail to induce transformation of hematopoietic cells (Skorski et al., 1997) .
Constitutive phosphorylation ofAkt depends on the integrity of its PH domain and correlates with its responsiveness to PDGF stimulation Total cell lysates of the Akt transfectants used in the experiment shown in Figure 1 were also electrophoresed in an 8.5% SDS ± PAGE and they were blotted on Immobilon-P membranes. The resulting Western blots were probed with the HA11 antibody. The results ( Figure 2 ) revealed that Akt expressed in serum-starved cells migrates as two distinct electrophoretic forms. Wild-type Akt gives rise predominantly to the slower migrating form. However, Akt mutants that fail to respond to PDGF give rise primarily to the faster migrating form. To determine whether the slower migrating form of Akt is due to phosphorylation, immunoprecipitates of serum-starved NIH3T3 cells transfected with wild-type, E40K and R25E Akt were electrophoresed in 8.5% SDS ± PAGE before and after treatment with l phosphatase in the presence or absence of the phosphatase inhibitor vanadate. The results ( Figure 3) showed that phosphatase treatment leads to the loss of the slow migrating Akt form and that this is inhibited by the vanadate. This con®rmed that the slow migrating form is phosphorylated. The kinase-inactive Akt K179M gives rise to both Akt 
Mutants whose properties are not explicitly described in the text. f,g These mutants are inactive forms, suggesting that the pre-activation phosphorylation event, described here, is likely to be the result of transphosphorylation ( Figure 2b ). Moreover, since serum-starved phosphorylation occurs in serumstarved cells, we conclude that this PH domaindependent phosphorylation event is constitutive and growth factor-independent. The experiments in Figures 1 and 2 revealed a correlation between the phosphorylation status of Akt prior to stimulation and its responsiveness to growth factors. To de®ne the site(s) of phosphorylation responsible for the slow migrating Akt form, we followed a genetic approach. Recent studies have shown that Akt is phosphorylated on two residues (serine 124 and threonine 450) in serum-starved 293 cells (Alessi et al., 1996) . The Akt mutants S124A, S124D, T450A, T450D were therefore constructed and their electrophoretic mobility was determined in transiently transfected, serum-starved NIH3T3 cells before and after PDGF stimulation and/or wortmannin treatment. The results (Figure 4a ) revealed that while the S124A and S124D mutants give rise to the two dierentially phosphorylated forms, the T450A mutant gives rise to only the faster migrating nonphosphorylated form. Moreover, a T450D mutant, which mimics phosphorylation at T450, gives rise to only the slower migrating form (Figure 4a ). These results show that PH domain mutations inhibiting the activation of Akt by PDGF impair constitutive phosphorylation at threonine 450 and they may or may not aect phosphorylation at S124. To further con®rm that the PH domain mutations aect constitutive phosphorylation of Akt at threonine 450, we analysed the migration pro®le of the double mutants E40K/T450A and R25A/T450D. The results showed that E40K/T450A migrates as a single fast migrating band, whereas R25A/T450D migrates as a single slow migrating band (Figure 4b ).
To determine whether the activation of Akt by PDGF is causally linked to its constitutive phosphorylation, we examined the kinase activity of the constitutive phosphorylation site mutants before and after PDGF stimulation. The results revealed that both the S124A and the T450A as well as double S124A/ T450A mutant continue to respond to PDGF Figure 2 Akt migrates as two electrophoretically distinct forms in serum-starved cells, whose ratio is modulated by PH domain mutations. Western blot analysis with the anti-hemagglutinin tag antibody HA11 of total lysates of NIH3T3 cells transiently transfected with wild-type Akt and PH domain mutants. (a) Wildtype Akt, E40A, E40C and E40K mutants migrate as two electrophoretically distinct forms, the predominant one being the slow migrating form. In addition to the two electrophoretic forms of Akt detected in serum-starved cells, PDGF stimulation of wildtype Akt-expressing cells gives rise to an even slower migrating Akt form that is due to phosphorylation (Kohn et al., 1995; Burgering and Coer, 1995 , also see subsequent experiments) and correlates with increased kinase activity (activation-associated phosphorylation). The stoichiometry of the PDGF-induced phosphorylation is lower than that induced by insulin. Because of this, the intensity of the phosphorylated band sometimes drops below the level of detection. A fraction of the molecules of all E40 mutants that exhibit enhanced basal kinase activity also undergo activation-associated phosphorylation in the absence of stimulation. (b) Inactive PH domain mutants R25A, R15A and W22A express mostly the faster migrating form. The ratio to the two electrophoretic forms is not aected by PDGF stimulation or wortmannin treatment Figure 3 The slow migrating Akt form in serum-starved cells is due to phosphorylation. Western blot of anti-HA11 immunoprecipitates of serum-starved NIH3T3 cell lysates transiently transfected with HA-tagged wild-type Akt and PH domain mutants were probed with the HA11 antibody. Some of the immunoprecipitates were treated with l-phosphatase in the presence or absence of the phosphatase inhibitor, sodium vanadate, as indicated (Figure 4c ). These data therefore suggest that although constitutive phosphorylation of Akt at S124 and T450 may contribute, it is not required for Akt activation by growth factors. However, since its almost complete abrogation fully correlates with PH domain mutations that prevent activation of Akt by growth factors, we suggest that constitutive phosphorylation and the response of Akt to growth factor stimulation both depend on a common event that is PH domaindependent and growth factor-independent.
Growth factor stimulation induces membrane translocation of Akt. Non-activatable PH domain mutants ofAkt do not translocate to the membrane following stimulation
Our earlier studies had shown that Akt translocates to the cell membrane following growth factor stimulation (Ahmed et al., 1997) . Moreover, studies from this and other laboratories had shown that a myristylated mutant of Akt is constitutively localized at the cell membrane and it is constitutively active (Ahmed et al., 1997; Kohn et al., 1996) . These data suggested that translocation of Akt to the cell membrane may play a role in Akt activation.
Since PH domain mutants that are not constitutively phosphorylated also fail to respond to PDGF, we questioned whether upon stimulation they translocate to the cell membrane. Failure to translocate would suggest that membrane localization plays a critical role in Akt activation by growth factors. In addition, it would suggest that a PH domain-dependent conformational change regulates both constitutive phosphorylation and membrane translocation. To address this question, NIH3T3 cells infected with retroviral constructs of wild-type Akt, Akt mutants R25C and E40K or vector only were plated on glass coverslips and serum-starved for 16 h. Some of the cultures were treated with wortmannin (200 nM) for 40 min, and subsequently, some of the cultures were stimulated with PDGF, as indicated. Immuno¯uorescence analysis was carried out with the anti-HA monoclonal antibody HA11. The results ( Figure 5 ) revealed that while wildtype Akt and Akt E40K translocate to the membrane following PDGF stimulation, R25C does not. Moreover, membrane translocation of wild-type and E40K Akt was inhibited by wortmannin, indicating that this process is PI3-K-dependent.
Forced membrane translocation of Akt PH domain mutants that fail to respond to PDGF is sucient to activate the Akt kinase
The preceding data revealed a correlation between the constitutive phosphorylation of Akt at threonine 450 by a PH domain-dependent, growth factor-independent phosphorylation event and membrane translocation and activation of Akt in response to PDGF. Moreover, they suggested that successful completion of this pre- Figure 5 Wild-type Akt and the E40K Akt mutant translocate to the cell membrane following PDGF stimulation. Non-activatable PH domain mutant R25C fails to translocate. Immuno¯uorescence analysis of NIH3T3 cells infected with retrovirus constructs of HA-tagged wild-type Akt and PH domain mutants using the HA11 antibody. In serum-starved cells, wildtype Akt and PH domain mutants are localized in the cytoplasm. Following growth factor stimulation, wild-type and E40K Akt translocate to the cell membrane, whereas the inactive PH domain mutant R25C fails to undergo membrane translocation. Membrane translocation is inhibited by wortmannin, and therefore it is PI3-K-dependent. Nuclei were stained with Hoechst 33258 activation step is required for membrane translocation which is a prerequisite for the activation of Akt by growth factors. To test this hypothesis, we examined whether non-activatable PH domain mutants became catalytically active when forced to translocate to the cell membrane. Such an outcome would suggest that constitutive signals transduced via the PH domain render the protein competent for translocation and that it is the translocation that is required for activation. To this end, NIH3T3 cells were transfected with CMV5 or CMV5-based expression constructs of wild-type Akt, myristylated wild-type Akt and myristylated mutants R25A, R25C, D11 ± 60 and K179M tagged at their carboxy-terminus with the HA epitope tag. Subsequently, the cells were lysed in an NP-40 lysis buer, and Akt was immunoprecipitated with the anti-HA monoclonal antibody. In vitro kinase assays on the Akt immunoprecipitates revealed that indeed non-activatable Akt PH domain mutants, similarly to wild-type Akt, become constitutively active when forced to translocate to the cell membrane ( Figure 6 ).
Threonine 308 and serine 473 mutants undergo constitutive phosphorylation and translocate to the membrane following PDGF stimulation but they are defective in activation
The preceding data indicate that Akt activation depends on two sequential steps, both of which require an Akt protein with an intact PH domain. The ®rst step regulates constitutive phosphorylation and responsiveness to growth factor stimulation. The second step, which appears to be dependent on the ®rst one, consists of the translocation of the protein to the cell membrane following stimulation. Forced membrane localization of Akt by addition of a myristylation signal to the amino-terminus of the protein bypasses the requirement for both these steps and activates Akt. This ®nding reinforces the signi®cance of membrane translocation in Akt activation and raises questions regarding the nature of the membraneassociated events.
Earlier studies had shown that stimulation of 293 cells by IGF-1 induces phosphorylation of T308 in the activation loop, and S473 in the kinase tail (Figure 7a and b) (Alessi et al., 1996) . Stimulation of NIH3T3 cells with PDGF induced phosphorylation of the same sites (data not shown). To determine the signi®cance of these stimulation-dependent phosphorylation events, we transiently transfected NIH3T3 cells with the Akt mutants T308A and S473A and examined their phosphorylation and catalytic activity before and after PDGF stimulation. For T308A, we also examined subcellular localization. The results showed that both mutants undergo constitutive phosphorylation in serum-starved cells and that T308A translocates to the cell membrane following stimulation (Figure 7c and  d) . However, T308A remains inactive while S473A is activated only partially.
T308 maps in the Akt activation loop and is¯anked by two additional threonines, T305 and T312 ( Figure  7b ). T305 is conserved between Akt, PKCa and PKCb whereas T312 is conserved between Akt, PKA, PKCa, PKCb, RSK and CDK2 and other kinases and corresponds to a phosphorylation site that contributes to the regulation of RSK activity (Sutherland et al., 1993) (Figure 7b ). Based on these considerations, and despite the fact that we did not have direct evidence for the phosphorylation of these sites following PDGF stimulation, we proceeded to mutate them into alanine. Interestingly, both the T305A as well as the T312A mutant failed to be activated by PDGF, suggesting that either these sites are also targets of phosphorylation, or that their mutation interferes with the phosphorylation of T308 (data not shown).
Phosphorylation of T308 and S473 occurs at the cell membrane and is required for activation. Forced membrane translocation fails to activate the Akt mutant T308A
Myristylated wild-type Akt in serum-starved cells migrates as three distinct electrophoretic bands which collapse into a single band following treatment with l phosphatase (Figure 8a1 ). The slowest migrating band is fully phosphorylated, whereas the other two bands correspond to the doublet generated by the partial constitutive phosphorylation of the kinase. Since the myristylated T308A Akt mutant lacks the slowest migrating band and is detected as a doublet that comigrates with the two faster migrating bands of the myristylated wild-type Akt (Figure 8a ), we conclude that the transition of myristylated Akt to the fully phosphorylated form requires phosphorylation at threonine 308. While myristylated Akt is partially phosphorylated at T308 in unstimulated cells, nonmyristylated wild-type Akt is not (Figure 8a2 , also see Figures 2a and 4b ). This experimentally con®rms the hypothesis that phosphorylation of T308 occurs at the cell membrane (Alessi et al., 1996 (Alessi et al., , 1997a Stokoe et al., 1997) .
Myristylated Akt is phosphorylated and is active both in the presence as well as in the absence of PDGF. Treatment of myristylated Akt immunoprecipitates with l phosphatase rendered the Akt kinase inactive. Moreover, while the myristylated wild-type Akt which is phosphorylated at T308 is active, the myristylated T308A mutant is inactive (Figure 8a1 ). These ®ndings, in combination with the ®ndings in Figure 7 , collectively show that phosphorylation of threonine 308 is required for Akt activation. Figure 8b also shows that the myristylated wild-type Akt undergoes phosphorylation at T308 and that it is active both in the presence and in the absence of PDGF. The phosphorylation of myristylated Akt at T308 in serum-starved cells indicates that the kinase Figure 6 Inactive PH domain Akt mutants are activated by forced membrane translocation. In vitro Akt kinase assays of anti-HA11 immunoprecipitates from NIH3T3 cells expressing wildtype Akt, myristylated wild-type Akt and myristylated inactive PH domain mutants HA-tagged at their carboxy terminus. Nonactivatable PH domain Akt mutants become constitutively active when forced to translocate to the cell membrane by the addition of the src myristylation signal. The myristylated version of the kinase inactive mutant K179M remains inactive phosphorylating Akt at this site is constitutively active. Indeed, PDK1 displays high constitutive activity in 293 cells (Alessi et al., 1997b) . Since stimulation with PDGF, however, increased the ratio of fully phosphorylated to nonphosphorylated Akt molecules and wortmannin inhibited this eect, we conclude that PDGF further stimulates T308 phosphorylation by a PI3-K-dependent mechanism (Figure 8b) .
Earlier studies had suggested that the phosphorylation of Akt at T308 by the upstream kinase PDK1 depends on PI3-K-generated phospholipids. The role of these phospholipids could be to render Akt a phosphorylation substrate for PDK1 by removing a PH domain constraint on T308 phosphorylation or to activate the Akt phosphorylating kinase (Stokoe et al., 1997; Alessi et al., 1997b) . Alternatively, these phospholipids could have a dual role (Stokoe et al., 1997) . The myristylated R25C mutant, which does not interact with D3 PPIs (Franke et al., 1997; Klippel et al., 1997) , is also activated by phosphorylation in vivo (Figure 6 ). This suggests that forced membrane translocation abrogates the PH domain constraint on Akt phosphorylation. This result combined with the data in Figure 8b showing that T308 phosphorylation of myristylated Akt is inhibited by wortmannin, suggests that it is the activation of PDK1 that is promoted by D3 PPIs.
PH domain mutations enhancing the Akt basal kinase activity reduce the phospholipid requirement for Akt phosphorylation by PDK1
The preceding data suggested that D3 PPIs promote PDK1 activation. To determine whether they also render Akt a phosphorylation substrate for this kinase, wild-type Akt and Akt E40K, immunoprecipitated from baculovirus-infected Sf9 cells, were used as substrates in PDK1 in vitro kinase reactions, in the presence of increasing concentrations of PI(3,4,5)P3. The results (Figure 9 ) revealed that E40K is phosphorylated by PDK1 in the presence of phospholipid concentrations that were too low to permit phosphorylation of wild-type Akt. Therefore, the E40K mutation reduces the phospholipid requirement for Akt phosphorylation thus con®rming that the D3 PPIs function by interacting with the Akt PH domain thus rendering Akt a substrate for PDK1. This is in agreement with data in Figure 2 showing that a fraction of the molecules of all E40 Akt mutants undergo activation-associated phosphorylation even under conditions of serum starvation in NIH3T3 cells. The results of the in vitro kinase reaction in Figure 9 recapitulate faithfully the in vivo data in Figure 2 . Collectively, therefore, the data presented here and in the preceding section provide strong support for a dual role of the D3 PPIs in Akt activation. In addition to their implications regarding the target of the D3 PPIs, the data in Figure 9 also suggest that E40K binds phospholipids more eciently than wild-type Akt, in agreement with the Akt PH domain structural model.
Discussion
The data presented in this report are consistent with a three-step model of Akt activation. As a result of the ®rst step, Akt assumes an activatable conformation which is marked by the constitutive phosphorylation of T450. The second step involves the translocation of Akt to the cell membrane and the third and last step is de®ned by the phosphorylation of Akt at T308 and S473 (Figure 10 ). The three steps appear to occur sequentially in a predetermined order.
Experiments supporting the ®rst step were based on Akt PH domain mutants that either exhibit enhanced basal kinase activity or they are defective in their responsiveness to growth factor stimulation. To generate these mutants, we used a structural model of the Akt PH domain which was built by comparative modeling. This structural model is supported by ®ndings showing that all the mutations in the predicted phospholipid binding pocket aect PH domain function. Moreover, the Akt residues R15, R25 and E40, which are predicted to lie in the phospholipid binding pocket of Akt, structurally align with the corresponding residues K12, R28 and E41 in the recently published structure of the Btk PH domain (Hyvonen and Saraste, 1997) .
Our data showed that the ®rst step depends on the integrity of the PH domain but it occurs in serumstarved cells, is not aected by wortmannin and is therefore growth factor-and PI3-K-independent. This indicates that the PH domain is involved in Akt activation by growth factors not only by binding to PI3-K-generated phospholipids but also by binding to molecules that are not regulated by PI3-K. Molecules that may have such a role include phospholipids other than D3 PPIs or D3 PPIs persisting after serum starvation (Khwaja et al., 1997) . Alternatively, the ®rst step may be mediated by binding to chaperonins (Hartl, 1996) . Recent evidence suggests that several protein kinases, including cdk4, v-src, Raf and Sevenless, may be regulated by binding to a complex of cdc37 and the associated heat-shock protein Hsp90. Based on this, it was proposed that the cdc37/Hsp90 complex may act as a molecular chaperone involved in regulating the folding of these kinases (Hunter and Poon, 1997) . Protein kinases that are regulated by this complex undergo degradation following treatment with geldanamycin, an Hsp90 inhibitor. Interestingly, recent data showed that geldanamycin also induces Akt degradation and suggested that Akt may also be regulated by this complex (Bellacosa et al., unpublished) . et al., submitted) . Both wild-type and E40K Akt are phosphorylated by PDK1 in the presence of D3-phosphorylated phospholipids. However, wild-type Akt is phosphorylated only in the presence of 10 mM PI(3,4,5)P3, whereas E40K is phosphorylated at PI(3,4,5)P3 concentrations ranging from 1 ± 3 mM. The results are representative of three experiments Figure 10 A three-step model of Akt activation. The model is supported by data from a systematic examination of the temporal and spatial order of Akt activation by growth factors that was based on a combination of structural, genetic and pharmacological approaches. For details see text. *Phosphorylation at T450 is an indicator of completion of the ®rst step but it is not required for Akt activation
The inactive PH domain mutants described in this paper could be defective both in the ®rst as well as the second and third activation steps that depend on binding to D3 PPIs. A likely exception to this could be the mutant K14A which, based on our structural model of the PH domain, should bind phospholipids. Therefore, the K14A mutant may provide a genetic tool that distinguishes the ®rst from the second step of Akt activation. Wild-type Akt and mutant proteins responsive to PDGF stimulation undergo constitutive phosphorylation at T450, while mutants unresponsive to such stimulation do not. This suggests that, during the ®rst step, the Akt protein assumes, perhaps through interaction with chaperonins, a conformation that renders it a substrate for the T450 kinase as well as for subsequent PDGF-triggered activation events. Mutations in the constitutive phosphorylation sites revealed that although not required for activation by growth factors, constitutive phosphorylation promotes Akt activation.
The second step, translocation to the membrane, appears to depend on the successful completion of the ®rst step. Akt mutants that fail to complete the ®rst step, and therefore are only partially phosphorylated at T450, do not translocate to the cell membrane following PDGF stimulation. Similarly to the ®rst step, successful completion of the second step also depends on the integrity of the PH domain. However, unlike the ®rst step, the second step is induced by growth factor stimulation, is inhibited by wortmannin and is therefore PI3-K-dependent. These ®ndings suggest that the second step is regulated by binding of PI3-K-generated D3 PPIs to the PH domain. The membrane anchoring of PH domain-containing proteins via the interaction of the PH domain with membrane lipids has been suggested for several proteins including PLC-d1 (Paterson et al., 1995) , SOS (Chen et al., 1997) , IRS-1 (Yenush et al., 1996) and pleckstrin .
The third and last step in the process of Akt activation consists of phosphorylation at T308 and S473 and perhaps other residues surrounding T308. The data in this report show that phosphorylation of T308 (and perhaps S473) occurs at the cell membrane. Thus, the myristylated wild-type Akt protein, which is constitutively associated with the cell membrane, is also constitutively phosphorylated at T308 (Figure 8a1, 8b) , while the cytosolic wild-type protein is not phosphorylated at these sites under the same conditions ( Figure  8a2 ). The data presented in this paper also show that phosphorylation at these sites is required for Akt activation. Thus, treatment of immunoprecipitates of activated wild-type Akt or myristylated Akt with l phosphatase renders them catalytically inactive. In addition, PDGF stimulation fails to activate the Akt T308A mutant and only partially activates the S473A mutant. Finally, addition of a myristylation signal at the amino-terminus of the Akt mutant T308A failed to activate it. These ®ndings combined with the fact that a double Akt mutant T308D/S473D is constitutively active (Alessi et al., 1996 and data not shown) suggest that the purpose of the multiple step process of Akt activation is likely to be its phosphorylation at these sites.
Phosphorylation of Akt following growth factor stimulation is due to at least two additional kinases, PDK1 and PDK2 (Alessi et al., 1997a,b; Stokoe et al., 1997) . Phosphorylation of Akt by these kinases in vitro depends on the addition of P1(3,4,5)P3 or PI(3,4)P2 (Alessi et al., 1997a, b; Stokoe et al., 1997) . This suggested that either the PDKs respond to PI3-Kgenerated phospholipids or that the phospholipids are required to render Akt a substrate of these kinases. Alternatively, both Akt and the PDKs may be direct targets of the PI3-K (Stokoe et al., 1997) . Our data support a model according to which PI3-K targets both Akt and the PDKs. Thus, myristylated PH domain mutants that do not bind D3 PPIs are activated by phosphorylation, suggesting that forced membrane translocation abrogates the constraint imposed by the PH domain on the phosphorylation of Akt. Moreover, phosphorylation of myristylated Akt at T308 is enhanced by PDGF and inhibited by wortmannin in vivo (Figure 8b ). These data collectively suggest that D3 PPIs activate PDK1. On the other hand, PH domain mutants with enhanced basal kinase activity undergo activation-associated phosphorylation under conditions of serum starvation in vivo ( Figure  2a ) and display reduced phospholipid requirement for Akt phosphorylation by PDK1 in vitro (Figure 9 ). This suggests that the D3 PPIs may bind the PH domain and render Akt a substrate for PDK1. Therefore, our studies support a dual role of the D3 PPIs in Akt activation. The phosphorylation of the Akt E40K mutant in the presence of low concentrations of D3 PPIs also suggests that the E40K mutation may enhance D3 PPI binding to the PH domain. Experiments addressing the anity of D3 PPI binding to the E40K and other Akt PH domain mutants are in progress.
The data in this report show that the PH domain of Akt may regulate diverse processes contributing to Akt activation. The role of one of these processes is to place Akt in an activatable conformation that permits its membrane translocation following stimulation by PDGF Since this process does not appear to depend on the activity of PI3-K, we assume that it also does not depend on binding to PI3-K-generated phospholipids. Given that the Akt PH domain also functions as a protein-protein interaction module , we propose that its involvement in this process may be due to its interaction with other proteins such as chaperonins (Hartl, 1996) . The role of the PH domain in subsequent steps of Akt activation appears to be mediated by its interaction with D3 PPIs. Interaction of the Akt PH domain with such phospholipids at the cell membrane is likely to accomplish two goals. First it may promote and stabilize membrane translocation and membrane anchoring of the Akt kinase. In addition, interaction with these phospholipids may remove a PH domain constraint on Akt phosphorylation and thus render Akt a substrate for Akt phosphorylating kinases. The same phospholipids may activate membrane-associated kinases that phosphorylate Akt.
Materials and methods
Computer modeling of the N-terminal PH domain of Akt
The coordinates of both PLCd and pleckstrin N PH domains were retrieved from the PDB database. A hybrid structural template of PLCd and pleckstrin N PH domains was generated by using the program O (Jones et al., 1991) . Sequence alignment between the Akt and the hybrid PH domain was followed by the building of a structural model of the PH domain of Akt using the method of comparative modeling (Sali and Blundell, 1990) . After some minor manual adjustments, the model was energy-minimized using Xplor (Brunger, 1992) . The electrostatic energy potential was calculated using Grasp (Nicholls et al., 1991) .
Akt constructs and site-directed mutagenesis
The CMV5 expression constructs of wild-type Akt and the mutants R25C and K179M tagged at their amino-terminus with a hemagglutinin (HA) epitope tag were described previously . The CMV6 expression construct of wild-type Akt tagged as its carboxy-terminus with the HA epitope tag and at its amino-terminus with the c-src-derived myristylation signal (MGSSKSKPK) has also been previously described (Ahmed et al., 1997) . Additional mutants were generated by overlap-extension PCR (Higuchi et al., 1988) using oligonucleotide primers prepared by the FCCC DNA synthesis facility. To verify the mutations and to con®rm that unwanted mutations were not inadvertently introduced, all cloned PCR products were sequenced using an automated DNA sequencer (ABI). Double and triple mutants as well as myristylated mutants were generated by exchanging mutation-bearing restriction fragments.
Cell culture, transfections and infections NIH3T3 cells were cultured at 378C and 7.5% CO 2 in Dulbecco's modi®ed Eagle's minimum essential medium (DMEM) supplemented with 10% calf serum, penicillin (50 units/ml), streptomycin (50 mg/ml) and kanamycin (100 mg/ ml) (PSK). 293T cells (gift of Dr Jonathan Cherno, FCCC) were cultured at 378C and 7.5% CO 2 in DMEM supplemented with 10% fetal bovine serum (FBS) and PSK.
Transient transfections of NIH3T3 cells and 293T cells seeded in 60 mm Petri dishes at 0.5610 6 cells/dish were carried out using 4 mg of DNA and LipofectAMINE (Life Technologies, Inc.) according to the manufacturer's protocol. Twenty-four hours later, cells were washed twice with Dulbecco's phosphate buered saline (PBS), and then cultured in serum-free DMEM overnight (typically, for 16 h). The next day, cells were stimulated with PDGF-AB (Life Technologies, Inc.) at a concentration of 50 ng/ml for 10 ± 15 min. For wortmannin treatment, cells were exposed to the drug at a concentration of 200 nM 40 min prior to PDGF-AB stimulation.
For infections, wild-type Akt and R25C, E40K and T308A mutants were cloned in the retroviral vector SRa. NIH3T3 cells were infected with high-titer ecotropic viral supernatants, prepared from 293T cells cotransfected with these constructs and the plasmid PY-E-MLV (gift of Dr Nathaniel Landau). Infected cells were selected for G418 resistance. Since the selection was carried out for only 1 week, uninfected cells were still present in the cultures submitted to immuno¯uorescence analysis.
Western blotting
Cells were washed twice with cold PBS and then lysed on ice in a Nonidet P-40 (NP-40) lysis buer (20 mM Tris HCl pH 8, 137 mM NaCl, 10% glycerol, 1% NP-40, 10 mM NaF, 1 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM dithiothreitol, 1 mM EDTA), containing 1 mM phenylmethylsulfonyl¯uoride, 5 mg/ml aprotinin and 5 mg/ml leupeptin. For Western blotting, lysates were separated by SDS-polyacrylamide gel electrophoresis (SDS ± PAGE) (8.5%) and transferred to PVDF membranes (Immobilon P, Millipore) with an X-genie electroblotter (Idea Scienti®c). Membranes were blocked by incubation in a solution of 4% dry milk (Carnation) in PBS for 16 h and then probed with the anti-HA monoclonal antibody HA11 (Berkeley Antibody Company) diluted 1/1000 in 1% dry milk in PBS for 2 h. Following incubation with a goat anti-mouse antibody coupled to horseradish peroxidase (Amersham), detection of antigen-bound antibody was carried out using enhanced chemiluminescence (ECL, Amersham), according to the manufacturer's protocol. Intensity of individual bands was quantitated with the N1H Image software following scanning of ®lms exposed in the linear range.
Immunoprecipitation and in vitro kinase assays
For immunoprecipitation, NP-40 lysates were clari®ed by centrifugation at 10 000 g for 10 min and precleared by incubation with 25 ml of a 50% suspension of protein A agarose beads (Life Technologies, Inc.) at 48C for 20 min. The beads were removed by centrifugation at 10 000 g for 10 min and the precleared lysates were incubated with the anti-HA antibody HA11 (dilution 1/500) for 90 min at 48C. Thirty ml of a 50% suspension of protein A-protein G beads (1 : 1) were then added and the incubation continued for an additional 45 min. Immunoprecipitates were washed three times with NP-40 lysis buer, once with 50 mM Tris HCl pH 7.4 and once with Akt kinase buer (20 mM HEPES pH 7.4, 10 mM MgCl 2 , 10 mM MnCl 2 , 1 mM dithiothreitol). Immunoprecipitates were then incubated at room temperature for 15 min in 20 ml of Akt kinase buer plus 50 mg/ml leupeptin, 50 mg/ml aprotinin, 0.1 mg/ ml histone H2B (Boehringer-Mannheim), 2 mM ATP and 10 mCi of [g 32 P]ATP (3000 Ci/mmol, Amersham). The kinase reactions were stopped by the addition of 7 ml of 46 sample loading buer (1 M urea, 120 mM Tris HCl pH 6.8, 100 mM dithiothreitol, 3% SDS, 10% glycerol and 0.02 % bromophenol blue), separated by SDS ± PAGE in 12.5% gels and electroblotted onto PVDF membranes. Membranes were exposed to Re¯ection NEF-496 ®lm (Dupont) and the intensity of individual histone H2B bands was quantitated with a PhosphorImager (Fuji). Akt speci®c kinase activity was calculated from the ratio of the intensity of the H2B band, phosphorylated by Akt in in vitro kinase assays, vs the intensity of the Akt band in Western blots of the corresponding lysates.
To determine the phosphorylation of wild-type and E40K Akt by PDK1 in vitro, the two proteins were expressed in Sf9 cells and immunoprecipitated using anti-HA-sepharose beads. After washing the beads, a slurry containing 0.5 mg protein was incubated in a buer containing 5 mM MgCl 2 , 10 mM ATP, 0.5% NP-40, 20 mM Tris HCl pH 7.5, 10 mCi [g 32 P]ATP with or without 0.05 ml PKB kinase puri®ed from sheep brain (Stokoe et al., 1997; Stephens et al., submitted) , and indicated concentrations of (1-stearoyl, 2-arachidonyl) snphosphatidyl D-myoinositol (3,4,5)-trisphosphate (PI(3, 4,5)P3) in a ®nal volume of 10 ml. After 15 min at 308C, sample buer was added and the components separated by SDS ± PAGE on a 7% gel. The gel was dried and autoradiographed, and the radioactivity quantitated by counting the bands in the presence of liquid scintillant.
Phosphatase treatment
Cells were lysed and immunoprecipitations were carried out as above. Immunoprecipitates were washed three times with NP-40 lysis buer lacking phosphatase inhibitors (NaF, sodium pyrophosphate and sodium orthovanadate), once with 50 mM Tris HCl pH 7.4 and once with l phosphatase buer (Zhuo et al., 1993 ). Immunoprecipitates were then incubated at 308C for 30 min in 40 ml of l phosphatase buer alone or l phosphatase buer containing 400 units of l phosphatase (New England Biolabs) with or without 1 mM sodium vanadate, a phosphatase inhibitor. Immunoprecipitates were then washed three times with complete NP-40 lysis buer, once with 50 mM Tris HCl pH 7.4 and once with Akt kinase buer. Akt kinase assays were performed as described above. An aliquot of the immunoprecipitates was separated by SDS ± PAGE (8.5 %) and analysed by Western blotting.
Immuno¯uorescence NIH3T3 cells infected with retroviruses encoding wildtype, mutant Akt or empty vector were plated on glass coverslips. Two days later, cells were serum-starved, and the next day they were stimulated with PDGF-AB as above. Following stimulation, the coverslip-attached cells were ®xed in 3.5% fresh paraformaldehyde in PBS pH 6.9 for 7 min, permeabilized with IF buer (10 mM Tris HCl pH 7.5, 150 mM NaCl and 0.1% [w/v] bovine serum albumin) containing 0.2% Triton X-100 for 7 min, washed in IF buer and then blocked in 10% goat serum in IF buer for 20 min. Cells were then incubated with the anti-HA tag monoclonal antibody HA11 at 1 : 200 dilution in IF buer at room temperature for 45 min, and washed four times in IF buer. After incubation with a goat anti-mouse antibody coupled to¯uorescein isothiocyanate (FITC) (Sigma) for 45 min (dilution 1 : 200) and four additional washes, cell nuclei were stained with Hoechst 33258 (0.5 mg/ml). Coverslips were mounted on microscope slides with anti-fade solution (Sigma) and examined by confocal microscopy (Biorad). Each reported FITC image is a composite of three sequential sections through the cell nucleus.
